By elucidating the molecular pathways through which CNPY3 impacts tumor and stromal cell interactions, this research aims to provide a foundation for new therapeutic approaches that disrupt supportive microenvironment interactions in CC. This evidence concerns the gene CNPY3 and neoplasm.